Ebola Virus Disease: Comprehensive Guide to Transmission, Symptoms, and Prevention

Ebola virus disease (EVD) is caused by viruses in the genus Orthoebolavirus (family Filoviridae). Six species identified; four cause human disease (Zaire, Sudan, Bundibugyo, Tai Forest ebolavirus).

Transmission

  • Direct contact with blood/body fluids of symptomatic infected persons or recent deceased.
  • Contact with contaminated objects (needles, bedding, clothing).
  • Contact with infected animals (bats, primates) or raw bushmeat.
  • Sexual transmission via semen (virus persists months after recovery).
  • Not airborne, waterborne, or foodborne (except bushmeat). No insect vectors.

Symptoms (2–21 day incubation)

Early ("dry" phase): Fever, severe headache, muscle/joint pain, weakness, fatigue, sore throat.

Late ("wet" phase): Vomiting, diarrhea, abdominal pain, rash, hiccups, impaired kidney/liver function, unexplained bleeding (gums, nose, injection sites, GI tract).

Diagnosis

RT-PCR (blood) detects viral RNA. Rapid antigen tests available for field use. Requires BSL-4 or BSL-3 with enhancements for culture.

Treatment

  • Supportive care: Aggressive IV fluids/electrolytes, oxygen, blood products, vasopressors, management of coagulopathy, organ support.
  • Specific antivirals (for Zaire ebolavirus): Inmazeb (atoltivimab/maftivimab/odesivimab), Ebanga (ansuvimab)—monoclonal antibodies. Reduce mortality significantly when given early.

Prevention

  • Avoid contact with infected fluids/bodies.
  • PPE for caregivers/health workers.
  • Safe burial practices.
  • Vaccine: rVSV-ZEBOV (Ervebo) for Zaire ebolavirus—highly effective, used in ring vaccination.
  • Hand hygiene, community engagement, survivor support (reduce stigma, monitor semen persistence).

Outbreak Control

Rapid case detection, isolation, contact tracing (21-day monitoring), ring vaccination, safe burials, and community trust are pillars of containment.

Viral Infections - Related Articles